Patient-reported outcomes in the regulatory approval of medical devices

Common blood pressure drug does not slow down the progression of more advanced Alzheimer’s

November 15, 2021

New research led by the University of Bristol, has shown the drug losartan, normally used to treat high blood pressure (hypertension), is not effective in slowing down the progression of Alzheimer’s disease (AD) in people with mild-to-moderate disease after 12 months of treatment. However, the drug could still be of benefit if prescribed for longer and if given to people with very early disease.

Patient-reported outcomes in the regulatory approval of medical devices

Common blood pressure drug does not slow down the progression of more advanced Alzheimer’s

Bristol childhood obesity clinic forms blueprint for national NHS pilot